HOME >> BIOLOGY >> NEWS
Researchers Discover Mechanism Of Cleft Palate Development

Researchers led by a team of UC San Francisco scientists have identified the mechanism by which a disfiguring birth defect wreaks its havoc. Cleft palate, the most common craniofacial birth defect in humans, occurs when the two sides of the palate do not properly fuse during fetal development, leaving an opening or cleft in the roof of the mouth.

Earlier research had already established that abnormalities in the gene for Transforming Growth Factor Alpha (TGF-a) were linked to cleft lip and palate syndromes. TGF-a is a growth factor with many known functions yet how it related to cleft palate was a mystery until now.

The inter-institutional group, led by Rik Derynck, PhD, UCSF professor of cell biology in the Department of Growth & Development, and Zena Werb, PhD, UCSF professor of cell biology in the Department of Anatomy, demonstrated that during normal embryonic development, docking of the molecule TGF-a with the Epidermal Growth Factor Receptor (EGFR), results in the production of a class of proteins called matrix metalloproteinases (MMPs).

Using "genetic knock-out" mice specially bred without the EGFR, the researchers learned that after activation of the EGFR, MMPs regulate the closure of the palate. Palate closure must be closely coordinated with the development of the lower jaw, a process regulated by MMPs. Simply put, if EGFR does not function properly when TGF-a joins with it, MMPs are not produced and cleft palates frequently result. The study is reported in the May 1999 issue of the journal Nature Genetics.

"This study has provided a developmental basis for the correlation between EGFR functioning and cleft palate syndrome but also illuminates the development mechanism for palate closure," says Derynck. "The role of this receptor in palate closure is through its ability to induce the activity of proteases. This is an intriguing finding because we believe that this animal study will translate very closely to humans."

With the
'"/>

Contact: James Larkin
jlarkin@pubaff.ucsf.edu
415-750-6633
University of California - San Francisco
1-May-1999


Page: 1 2

Related biology news :

1. Researchers determine genetic cause of Timothy syndrome
2. Researchers find color sensitive atomic switch in bacteria
3. Researchers identify protein promoting vascular tumor growth
4. Researchers devise potent new tools to curb ivory poaching
5. Researchers create nanotubes that change colors, form nanocarpet and kill bacteria
6. Researchers ID chlorophyll-regulating gene
7. Researchers develop fast track way to discover how cells are regulated
8. Researchers identify distinctive signature for metastatic prostate cancer
9. Researchers report new gene test for isolated cleft lip and palate
10. Researchers discover why mutant gene causes colon cancer
11. Researchers identify the genomes controlling elements

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:11/27/2019)... ... November 25, 2019 , ... Though the forecast for ... more than 55 million travelers expected to hit the roads and the skies. It’s ... it’s weight in truffle oil will offer a simple design, mouth-watering pictures of food, ...
(Date:11/27/2019)... MONTREAL (PRWEB) , ... November 27, 2019 , ... ... features a sleek hand-held device, equipped with surface electromyography (sEMG) sensors that measure ... ensure the activation of the specific muscles being targeted for treatment. Both patient ...
(Date:11/19/2019)... , ... November 19, 2019 , ... Project Lifeline ... Chain Drug Stores (NACDS) Foundation to address substance use disorder (SUD) – ... Two individuals who have led to the program’s effectiveness in preventing and treating opioid ...
Breaking Biology News(10 mins):
(Date:12/18/2019)... , ... December 18, 2019 , ... Tune in to ... hosted by Ted Danson. Check local listings for more information on this program. , ... augmented reality are helping to simplify complex system to increase the efficiency, safety and ...
(Date:12/6/2019)... ... December 06, 2019 , ... ... Inc. has received FDA 510(k) clearance for its latest CAPERE® Thrombectomy System ... data suggests the CAPERE® offers great benefits for first-in-line treatment for nonsurgical ...
(Date:12/4/2019)... ... December 03, 2019 , ... ... and services, today announced a partnership with the Recombinant Antibody Network (RAN), a ... and UC San Francisco (UCSF) with a common goal to generate recombinant antibodies ...
(Date:12/4/2019)... ... December 03, 2019 , ... A new study released today in ... and even reverse fibrosis (scar tissue) buildup – also improves the range of motion ... Medicine, was conducted on mice. , The tumor-destroying capabilities of radiation therapy can ...
Breaking Biology Technology:
Cached News: